Merck KGaA

Merck KGaA

MKGAF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$65.04B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Merck KGaAMerck KGaA27.41.47%6%3.20.4

Earnings Call Q3 2026

November 12, 2026 - AI Summary

Strong Q3 operating momentum; raised full-year guidance again - Organic group sales growth accelerated to 5.1% (vs 4.1% in Q2), with reported net sales +5.8% YoY (vs +3.4% in Q2). - Growth supported by Life Science (+6.1% organic) and Electronics (+13% organic); Healthcare improved sequentially, but remained pressured in parts. - Group profitability: EBITDA pre +0.8% YoY; earnings were impacted by a CDMO-related impairment (see negative point below). - Guidance upgraded for 2026 (third raise in the year): - Organic net sales: 3–4% (was 1–3%) → net sales ~EUR 21.5–21.9bn (was EUR 21.0–21.8bn). - EBITDA pre: EUR 6.2–6.4bn (was EUR 5.9–6.3bn), implying organic EBITDA pre growth 3–5%. - EPS pre: EUR 8.30–8.70 (was EUR 7.90–8.60).
Life Science: Process Solutions strong; Discovery steadier; tariffs largely “worked through” - Process Solutions organic +10.5% YoY in Q3 (+12.6% adjusted for tariff refund effects). Positive momentum across downstream/upstream/single-use. - Book-to-bill >1 (year-to-date September), indicating continued demand support. - Q4 for Process Solutions expected mid-single-digit organic growth due to phasing (explicitly: *not* implying weaker underlying market), and confidence in upper end of 2026 full-year 8–12% range. - Discovery Solutions organic +1.7% YoY in Q3 (more stable; reflects market stabilization), and Advanced Solutions organic +4.3%, helped by CDMO/biomonitoring/lab water; out of China grew, China slightly below prior year. - Tariff impact: all recognized by end of Q3; EUR 35m top-line YTD, EUR 26m in Q3. - 2026 Life Science guidance raised: organic sales 6–7% (was 5–7%), EBITDA pre organic 6–8% (unchanged range upward midpoint); includes Bio-Techne portfolio effect assumed in Dec 2026.
Electronics: Very strong Q3 growth driven by advanced nodes; pricing tailwind expected to fade - Electronics organic growth +13% in Q3; Semiconductor Solutions +19% organic. - Growth largely volume-driven with a temporary pricing contribution from tight raw material markets: - For full-year 2026, pricing ~~2 percentage points to organic sales growth (expected to mostly occur in Q3 (~1/3) and Q4 (~2/3)). - Base case: raw material conditions normalize through 2027, so the pricing tailwind fades. - Visibility: management cited continued tight capacity at leading-edge (advanced nodes); customers working to add capacity (Taiwan/Japan) → supports momentum into 2027. - 2026 Electronics guidance raised again: organic sales 10–11% (from 6–9%), EBITDA pre around EUR ~1.1bn with continued operating leverage.

Exclusive for Stockcircle Pro members

Sign upSign Up
$75.02

Current Fair Value

51.8% downside

Overvalued by 51.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$65.04 Billion
Enterprise Value$75.13 Billion
Annual dividend$2.58
Dividend yield1.47%
Earnings per Share$6
Beta0.83
Outstanding Shares434,777,878

Return

Return on Equity6.12%ROE
Return on Assets3.58%
Return on Invested Capital7.55%

Valuation & Multiples

P/E Ratio27.45P/E Ratio
PEG-54.78PEG
Price to Sales3.17Price to Sales
Price to Book Ratio2.16Price to Book Ratio
Enterprise Value to Revenue3.5
Enterprise Value to EBIT22.27
Enterprise Value to Net Income39
Total Debt to Enterprise0.18
Debt to Equity0.43Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
$2.63
Est. $2.47
Revenue
$6.29 B
Est. $6.20 B

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
$2.23
Consensus analyst estimate
Revenue Estimate
$6.09 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Merck KGaA

62,461 employees
CEO: Kai Beckmann

Merck KGaA is a venerable science and technology enterprise, headquartered in Darmstadt, Germany, where it was established in 1668. Operating as a subsidiary of E. Merck KG, the company organizes its diverse activities across three princ...

Questions & Answers